Your browser doesn't support javascript.
loading
Optimizing gentamicin conventional and extended interval dosing in neonates using Monte Carlo simulation - a retrospective study.
Bergenwall, Monique; Walker, Sandra A N; Elligsen, Marion; Iaboni, Dolores C; Findlater, Carla; Seto, Winnie; Ng, Eugene.
Afiliación
  • Bergenwall M; Department of Pharmacy, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, E-302, Toronto, ON, M4N 3M5, Canada.
  • Walker SAN; Present Address: Grandview Medical Centre Family Health Team, 167 Hespeler Rd, Cambridge, ON, N1R 3H7, Canada.
  • Elligsen M; Department of Pharmacy, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, E-302, Toronto, ON, M4N 3M5, Canada. sandra.walker@sunnybrook.ca.
  • Iaboni DC; Leslie L. Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada. sandra.walker@sunnybrook.ca.
  • Findlater C; Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. sandra.walker@sunnybrook.ca.
  • Seto W; Sunnybrook Health Sciences Centre Research Institute, Toronto, ON, Canada. sandra.walker@sunnybrook.ca.
  • Ng E; Department of Pharmacy, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, E-302, Toronto, ON, M4N 3M5, Canada.
BMC Pediatr ; 19(1): 318, 2019 09 06.
Article en En | MEDLINE | ID: mdl-31492162
ABSTRACT

BACKGROUND:

Although aminoglycosides are routinely used in neonates, controversy exists regarding empiric dosing regimens. The objectives were to determine gentamicin pharmacokinetics in neonates, and develop initial mg/kg dosing recommendations that optimized target peak and trough concentration attainment for conventional and extended-interval dosing (EID) regimens.

METHODS:

Patient demographics and steady-state gentamicin concentration data were retrospectively collected for 60 neonates with no renal impairment admitted to a level III neonatal intensive care unit. Mean pharmacokinetics were calculated and multiple linear regression was performed to determine significant covariates of clearance (L/h) and volume of distribution (L). Classification and regression tree (CART) analysis identified breakpoints for significant covariates. Monte Carlo Simulation (MCS) was used to determine optimal dosing recommendations for each CART-identified sub-group.

RESULTS:

Gentamicin clearance and volume of distribution were significantly associated with weight at gentamicin initiation. CART-identified breakpoints for weight at gentamicin initiation were ≤ 850 g, 851-1200 g, and > 1200 g. MCS identified that a conventional dose of gentamicin 3.5 mg/kg given every 48 h or an EID of 8-9 mg/kg administered every 72 h in neonates weighing ≤ 850 g, and every 24 and 48 h, respectively, in neonates weighing 851-1200 g, provided the best probability of attaining conventional (peak 5-10 mg/L and trough ≤ 2 mg/L) and EID targets (peak12-20 mg/L, trough≤ 0.5 mg/L). Insufficient sample size in the > 1200 g neonatal group precluded further investigation of this weight category.

CONCLUSIONS:

This study provides initial gentamicin dosing recommendations that optimize target attainment for conventional and EID regimens in neonates weighing ≤ 1200 g. Prospective validation and empiric dose optimization for neonates > 1200 g is needed.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Gentamicinas / Método de Montecarlo / Antibacterianos Tipo de estudio: Health_economic_evaluation / Observational_studies Límite: Female / Humans / Male / Newborn Idioma: En Revista: BMC Pediatr Asunto de la revista: PEDIATRIA Año: 2019 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Gentamicinas / Método de Montecarlo / Antibacterianos Tipo de estudio: Health_economic_evaluation / Observational_studies Límite: Female / Humans / Male / Newborn Idioma: En Revista: BMC Pediatr Asunto de la revista: PEDIATRIA Año: 2019 Tipo del documento: Article País de afiliación: Canadá